Company / CapEx per Share
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2025
5-year range
$0.01 / $0.07
FY2021-FY2025
Trend
-57.8%
vs FY2024
Sector context
#144 of 148
Health Care
What the data says
Among 148 Health Care companies, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is in the bottom 3% for capex per share. CapEx per Share has declined for 3 consecutive years, from $0.07 in FY2022 to $0.01 in FY2025.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of +8.8%.
Declined from $0.03 to $0.01 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -50.5%
- 5-Year CAGR
- +8.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 148This company $0.01 Sector average $1.67
▼
-99.5% below sector average
Key checks
Key Insights
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s capex per share has declined for 3 consecutive years.
- In FY2025, capex per share decreased 57.8% year-over-year.
- Ranks #144 out of 148 companies in the Health Care sector.
- Peak capex per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -57.8% |
| FY2024 | $0.02 | -38.5% |
| FY2023 | $0.03 | -53.3% |
| FY2022 | $0.07 | +156.7% |
| FY2021 | $0.03 | +389.3% |
| FY2020 | $0.01 | -68.1% |
| FY2019 | $0.02 | +16.6% |
| FY2018 | $0.02 | -85.8% |
| FY2017 | $0.11 | +9.7% |
| FY2016 | $0.10 | +734.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026